Skip to main content
CDT
NASDAQ Life Sciences

CDT Equity Completes 12.1M Share Warrant Exercise, Regains Nasdaq Compliance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.48
Mkt Cap
$1.164M
52W Low
$1.4
52W High
$2,719.4
52W Position info
5.7% above low
Off High info
100% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

CDT is trading near its 52-week low of $1.4 (5.7% above the low) on light trading volume (0.2× avg).

Summary

CDT Equity completed the cashless exercise of 12.1 million pre-funded warrants, increasing shares outstanding to 13.7 million and resolving Nasdaq listing deficiencies.


Key Events · Financing and Capital Events · CDT

  • Warrant Exercise Completed

    Investors exercised all 12,131,770 pre-funded warrants on a cashless basis, resulting in issuance of 12,131,122 shares of common stock.

  • Share Count Update

    Total shares outstanding as of August 31, 2026 is 13,693,866 shares, up from approximately 631,077 shares after the July reverse split.

  • Nasdaq Compliance Restored

    The company no longer has any outstanding deficiencies with The Nasdaq Stock Market LLC, resolving the delisting risk.

  • Market Capitalization

    Based on the August 31, 2026 closing price, market capitalization was approximately $23.0 million.


Analysis · CDT · Life Sciences

The cashless exercise of 12,131,122 pre-funded warrants has been completed, lifting total shares outstanding to 13,693,866. Market capitalization now stands at approximately $23 million, and all outstanding Nasdaq listing deficiencies have been resolved. This marks a critical milestone in the company's survival strategy, as it was previously facing a going concern warning and potential delisting.

How filings like this one have moved

In the 30 days to Sep 10, 2026, 30.1% of the 2014 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.11%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CDT was trading at $1.48 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.2M. The 52-week trading range was $1.40 to $2,719.40. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CDT - Latest Insights

CDT
Sep 08, 2026, 5:30 PM EDT
Filing Type: S-1
Importance Score:
9
Price at Filing: $0.6168
Real-time Price: $0.582 info
Change: -$0.0348 (-6%) info
Market Cap: $8.218M info
CDT
Sep 04, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.622
Real-time Price: $0.582 info
Change: -$0.040 (-6%) info
Market Cap: $8.218M info
CDT
Sep 02, 2026, 6:10 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.925
Real-time Price: $0.582 info
Change: -$0.343 (-37%) info
Market Cap: $8.218M info
CDT
Sep 01, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.58
Real-time Price: $0.582 info
Change: -$0.998 (-63%) info
Market Cap: $8.218M info
CDT
Aug 25, 2026, 5:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.81
Real-time Price: $0.582 info
Change: -$2.23 (-79%) info
Market Cap: $8.218M info